Joseph S. Zakrzewski
Net Worth

Last updated:

What is Joseph S. Zakrzewski net worth?

The estimated net worth of Mr. Joseph S. Zakrzewski is at least $240,200 as of 6 Feb 2024. He has received compensation worth at least $240,200 in Cyteir Therapeutics, Inc..

What is the salary of Joseph S. Zakrzewski?

Mr. Joseph S. Zakrzewski salary is $60,050 per year as Independent Investor & Chairman in Cyteir Therapeutics, Inc..

How old is Joseph S. Zakrzewski?

Mr. Joseph S. Zakrzewski is 63 years old, born in 1962.

What stocks does Joseph S. Zakrzewski currently own?

As insider, Mr. Joseph S. Zakrzewski owns shares in one company:

Company Title Shares Price per share Total value
Cyteir Therapeutics, Inc. (CYT) Independent Investor & Chairman 154,618 $0 $0

What does Cyteir Therapeutics, Inc. do?

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.

CYT logo
CYT
Cyteir Therapeutics, Inc.

Joseph S. Zakrzewski insider trading

Cyteir Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 14,150 $1.69 $23,914
Option
Common Stock 14,150 $1.69 $23,914
Purchase
Common Stock 21,202 $1.3 $27,563
Purchase
Common Stock 743 $1.61 $1,196
Purchase
Common Stock 1,000 $1.7 $1,700
Purchase
Common Stock 49,406 $1.89 $93,377
Purchase
Common Stock 601 $9.85 $5,920
Purchase
Common Stock 200 $9.97 $1,994
Purchase
Common Stock 99 $10.18 $1,008
Purchase
Common Stock 200 $9.87 $1,974
Purchase
Common Stock 200 $9.88 $1,976
Purchase
Common Stock 2,000 $10.47 $20,940
Purchase
Common Stock 1,700 $11.12 $18,904

Cyteir Therapeutics key executives

Cyteir Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Markus F. Renschler M.D. (64) Pres, Chief Executive Officer & Director
  • Dr. Paul Secrist Ph.D. (59) Chief Scientific Officer
  • Mr. Andrew W. Gengos (61) Chief Bus. Officer
  • Mr. Joseph S. Zakrzewski (63) Independent Investor & Chairman